# Evaluation of Safety and Effectiveness of Primary Hybrid Construct of Mobi-C and ACDF in the Treatment of Two-level Symptomatic Degenerative Disc Disease in the Cervical Spine.

> **NCT06485206** · NA · RECRUITING · sponsor: **Highridge Medical** · enrollment: 97 (estimated)

## Conditions studied

- Degenerative Disc Disease

## Interventions

- **DEVICE:** One level Mobi-C and one level fusion

## Key facts

- **NCT ID:** NCT06485206
- **Lead sponsor:** Highridge Medical
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-01
- **Primary completion:** 2029-05
- **Final completion:** 2029-05
- **Target enrollment:** 97 (ESTIMATED)
- **Last updated:** 2025-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06485206

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06485206, "Evaluation of Safety and Effectiveness of Primary Hybrid Construct of Mobi-C and ACDF in the Treatment of Two-level Symptomatic Degenerative Disc Disease in the Cervical Spine.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06485206. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*